4,6-Diiodopyrimidine - CAS 19646-06-1
Catalog: |
BB015193 |
Product Name: |
4,6-Diiodopyrimidine |
CAS: |
19646-06-1 |
Synonyms: |
4,6-diiodopyrimidine |
IUPAC Name: | 4,6-diiodopyrimidine |
Description: | 4,6-Diiodopyrimidine (CAS# 19646-06-1 ) is a useful research chemical. |
Molecular Weight: | 331.88 |
Molecular Formula: | C4H2I2N2 |
Canonical SMILES: | C1=C(N=CN=C1I)I |
InChI: | InChI=1S/C4H2I2N2/c5-3-1-4(6)8-2-7-3/h1-2H |
InChI Key: | LBVUFZJYMWUZIW-UHFFFAOYSA-N |
Boiling Point: | 333.883 °C at 760 mmHg |
Purity: | 98 % |
Density: | 2.765 g/cm3 |
MDL: | MFCD00233951 |
LogP: | 1.68580 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2019129237-A1 | Medicine carriable polyhydroxylated polymer embolism microsphere having contrast function and preparation method therefor | 20171228 |
AU-2018269666-A1 | Phenyl derivatives as PGE2 receptor modulators | 20170518 |
BR-112019024109-A2 | COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF A PHARMACEUTICALLY ACCEPTABLE COMPOUND OR SALT, METHOD OF MODULATING AN IMMUNE RESPONSE IN AN INDIVIDUAL WITH A TUMOR, AND, PROPHYLAXY OR TREATMENT METHOD | 20170518 |
CA-3060597-A1 | Phenyl derivatives as pge2 receptor modulators | 20170518 |
CA-3063788-A1 | Pyrimidine derivatives | 20170518 |
PMID | Publication Date | Title | Journal |
11277771 | 20010405 | Synthesis of oligopyridines and their metal complexes as precursors to topological stereoisomers | Organic letters |
Complexity: | 70.4 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 331.83074 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 331.83074 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.6 |
-
Catalog: BB079620
((4-bromo-3-(bromomethyl)butoxy)methyl)benzene
Detail
-
Catalog: BB078191
((3-Bromobenzyl)oxy)(tert-butyl)dimethylsilane
Detail
-
Catalog: BB051699
(1-(2,2-Difluoroethyl)-1H-pyrazol-4-yl)methanamine hydrochloride
Detail
-
Catalog: BB044156
(-)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB025409
(1-Bromo-2,2,2-trifluoroethyl)benzene
Detail
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS